XML 55 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Stockholders Equity [Line Items]  
Outstanding stock warrants (in Shares) | shares 4,904,016
Weighted average remaining contractual life (in years) 4 years 5 months 12 days
Weighted average exercise price for exercisable (in Dollars per share) | $ / shares $ 11.07
Equity plans description Under the 2018 Equity Plan, the number of shares issuable under the Plan on the first day of each fiscal year increase by an amount equal to the lower of (i) 100,000 shares (after a later 10 for 1 stock split) or (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year.  At the Company’s annual meeting on May 17, 2023, the stockholders approved an amendment to the 2021 Equity Plan that, amongst other things, increased the number of the shares available under the 2021 Equity Plan to 10,000,000 shares, and the shares available under the 2021 Equity Plan increased by 1,000,000 shares on January 1, 2024 to 11,000,000. Upon review of the previously granted shares in previous years and the availability of shares, on April 9, 2024, the Board of Directors approved the 2024 Omnibus Equity Plan which will provide an initial 10,000,000 shares of common stock available for grant per the terms of the 2024 Plan and provides alignment with long-term stockholder value creation. The 2024 Omnibus Equity Plan as approved by the Board of Directors has subsequently been presented to the stockholders for adoption and approval at the Company’s annual general meeting to be held on June 12, 2024.
shares based compensation $ 3,970
Stock based compensation surrendered shares. $ 930
Outstanding performance-based restricted stock (in Shares) | shares 75,545
Exercisable shares (in Shares) | shares 44,327
Performance-based awards [Member]  
Stockholders Equity [Line Items]  
Weighted average remaining contractual life (in years) 8 years 3 months 29 days
Unrecognized compensation cost $ 60
Restricted Stock Awards [Member]  
Stockholders Equity [Line Items]  
Unrecognized compensation cost 2,880
Stock Options Awards [Member]  
Stockholders Equity [Line Items]  
Unrecognized compensation cost $ 540
Common Stock [Member]  
Stockholders Equity [Line Items]  
Weighted average remaining contractual life (in years) 3 years 4 months 24 days